Plain-English translation of NCT06968832 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Prolonged Exposure Therapy (PE), a gold-standard treatment for PTSD, delivered in an intensive format (multiple times per week) alongside your substance use disorder treatment. Many people struggle with both PTSD and substance use at the same time, and this study is exploring whether receiving this focused therapy more frequently can improve outcomes for both conditions.
People who have both PTSD and substance use disorder often have worse outcomes and higher dropout rates from treatment than those with just one condition. Research suggests that delivering this therapy more intensively might help, and this trial aims to test whether that approach truly works better than standard care.
You likely qualify if…
You likely don't qualify if…
You'll be randomly assigned to receive either intensive Prolonged Exposure Therapy (multiple sessions per week over 2–4 weeks) combined with your regular substance use treatment, or standard substance use treatment that includes a weekly trauma skills group. Both groups continue in the intensive outpatient program for substance use, and you'll be assessed on your PTSD symptoms, substance use, mood, and other health outcomes throughout the study.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States